The BARF Project: A Pilot Study Using the BARF Scale to Assess CINV in Children

The Washington University

Status: Terminated

Conditions: Nausea

Treatments: Behavioral: Baxter Retching Faces (BARF) scale

Study type: Interventional

Funder types: Other

Identifiers

NCT04678947

202012147

Details and patient eligibility

About

In this pilot study, the Baxter Retching Faces (BARF) Scale will be used to assess chemotherapy induced nausea and vomiting (CINV) in the pediatric cancer population during chemotherapy admissions, and the corresponding administration of anti-emetic medications will be reviewed.

Enrollment: 6 patients

Sex: All

Ages: 4 to 12 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients diagnosed with cancer of any kind.
• Patients receiving inpatient chemotherapy at SLCH on the general pediatric oncology service
• Patients admitted for a course of inpatient chemotherapy scheduled to last at least 24 hours and but no more than 7 days.
• Patients who have received any prior cancer treatment, including radiation therapy, and/or surgery.
• Patients ages 4 to 12 years of age.
• Patient with a guardian who has the ability to understand English and the willingness to sign an IRB approved written informed consent document.

Exclusion criteria

• Any patient who is not undergoing inpatient chemotherapy on the general pediatric oncology service, including patients undergoing chemotherapy as conditioning for hematopoietic stem cell transplantation or other cellular therapy.
• Any patient who is receiving their first cycle of inpatient chemotherapy (however, they can be included during a future cycle).
• Any patient who is blind or unable to communicate by speaking or pointing.

Trial design

Primary purpose: Health Services Research

Allocation: Non-Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

6 participants in 2 patient groups

BARF scale

Experimental group

Description:

* Nursing staff (which may include patient technicians and nursing assistants) will use the scale to assess the patient's nausea for the entire duration of the admission. These assessments will take place in conjunction with vital sign monitoring, every 4 hours. The associated script will be read while the laminated scale is shown to the patient. * The nurse will then log the patient's response in the patient's electronic medical record

Treatment:

Behavioral: Baxter Retching Faces (BARF) scale

No intervention

No Intervention group

Description:

-Patients in the control group will proceed with their inpatient chemotherapy admissions without any interventions. These admissions will take place prior to the admissions of the experimental group, so as not to bias providers.